UnitedHealth Group (UNH)

NYSE · Healthcare · analysis, not advice

UNH

NYSE · Healthcare

UnitedHealth Group

WAITConfidence: MEDIUM

A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.

The panel

Warren BuffettWait · MEDIUM
DOJ investigation and MLR pressure cloud thesis. Wait for clarity before deploying capital.
Michael BurryBuy · MEDIUM
Contrarian setup — washed-out sentiment, dominant franchise, 5-year normalization likely.
Peter LynchWait · HIGH
Tenbagger candidates need clean stories. Too much regulatory noise to size up here.

Bottom line

Dominant franchise under regulatory cloud. Net WAIT until DOJ outcome visible.

Key levels

as of 2026-04-24

Key resistance

R1Immediate

515–530 USD

R2Strong

545–565 USD

R3Major

580–600 USD

Key support

S1Immediate

480–490 USD

S2Strong

450–465 USD

S3Major

410–430 USD

Current

498 USD

Analyst consensus target

538 USD

range 460 USD – 605 USD

Levels are informational analysis only — not entry, exit, or stop-loss recommendations.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Machine-readable version: https://verdixhq.com/api/verdict/UNH